Healthy Clinical Trial
Official title:
High Resolution Colonic Manometry in Relation to 3D-Transit Times in Healthy Controls.
Background: Within recent years, new methods for detailed assessment of gastrointestinal (GI)
motility have been developed. Hence, the electromagnetic 3D-Transit system is a safe,
non-invasive method for detailed description of GI motility. The system tracks the exact
position of an ingested electromagnetic capsule through the entire GI tract and provides
detailed information on both regional transit- and contraction patterns. High Resolution
Colonic Manometry (HRCM) allows extremely detailed description of contraction patterns in the
colon. The HRCM is however an invasive method, as the catheter is placed during colonoscopy.
Before widespread use of capsule-based techniques (3D-Transit or others), the system needs to
be validated by another method.
Study Objectives: The purpose of this study is to investigate weather pressure changes
measured by HRCM correlate with passage patterns recorded by 3D-Transit. This has been
assumed so far, but has never been further investigated.
Hypothesis: Movement of the electromagnetic 3D-Transit capsule within the colon correspond
well with pressure changes determined with HRCM.
Materials and methods: HRCM and 3D-transit will be performed simultaneously in 20 healthy
participants. A colonoscopy is performed to install the HRCM catheter and place two
3D-Transit capsules within the colon. For 24 hours, the participants lie in a bed in the
research lab while pressure changes from the HRCM catheter are recorded and the 3D-Transit
capsules are followed through the gastrointestinal system.
Perspectives: If data from the 3D-Transit technique correlate well with HRCM, the method
provide a non-invasive alternative allowing detailed assessment of colonic motility.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |